The aim of our study was to compare expression levels of PD-1 on immune cells, and PD-L1 on tumor cells and immune cells, in primary tumors and their matched distant metastases in a large group of breast cancer patients, and to evaluate prognostic values. The gene discussed is CD274; the disease is breast cancer.